DKK1 and breast carcinoma: The authors showed that the suppression of DKK-1 by statin and amino-bisphosphonates inhibited the ability of breast cancer cells to block WNT3A-induced production of alkaline phosphates and bone-protective osteoprotegerin in preosteoblastic C2C12 cells.